MeningococcalPolysaccharideVaccine

MeningococcalPolysaccharideVaccine Basic information
Product Name:MeningococcalPolysaccharideVaccine
Synonyms:MeningococcalPolysaccharideVaccine
CAS:
MF:
MW:0
EINECS:
Product Categories:
Mol File:Mol File
MeningococcalPolysaccharideVaccine Structure
MeningococcalPolysaccharideVaccine Chemical Properties
Safety Information
MSDS Information
MeningococcalPolysaccharideVaccine Usage And Synthesis
General DescriptionMeningococcal vaccine is an inactivated vaccine composedof capsular polysaccharide fragments of Neisseria meningitidis.There are four polysaccharide serotypes represented inthe vaccine: A, C, Y, and W-135. The type A polysaccharideconsists of a polymer of N-acetyl-O-mannosamine phosphate;the group C polysaccharide is mostly N-acetyl-Oacetylneuraminicacid. The antigens are conjugated to diphtheriatoxoid carrier. Indications are the following:
? Induction of active immunity against selected strains ofN. meningitidis
? Military recruits during basic training
? College freshmen and those living in dormitories
? Travelers to countries with epidemic meningococcal disease? Household or institutional contacts of those with meningococcaldisease
? Immunosuppressed persons (HIV, Streptococcus pneumoniae)
? To stop certain meningococcal group C outbreaks
? Persons aged 2 through 55 years of age at risk for invasivemeningococcal disease.
MeningococcalPolysaccharideVaccine Preparation Products And Raw materials
Tag:MeningococcalPolysaccharideVaccine Related Product Information